Review: Prophylactic use of Î²-carotene may increase the risk for all-cause mortality and cardiovascular death: COMMENTARY
- Assessment of Antioxidant Capacity of Natural Products. Niki, Etsuo // Current Pharmaceutical Biotechnology;Dec2010, Vol. 11 Issue 8, p801
No abstract available.
- Antioxidant Vitamins and Their Use in Preventing Cardiovascular Disease. Farbstein, Dan; Kozak-Blickstein, Adena; Levy, Andrew P. // Molecules;Nov2010, Vol. 15 Issue 11, p8098
Atherosclerosis remains one of the leading causes of death in Western populations. Subsequent to the discovery that oxidative stress plays a pivotal role in the development and progression of atherosclerosis, vitamins C and E, along with other antioxidants, were studied as potential therapies...
- Review: Prophylactic use of Î²-carotene may increase
the risk for all-cause mortality and cardiovascular death. // ACP Journal Club;Mar/Apr2004, Vol. 140 Issue 2, p45
The article focuses on the effectiveness of prophylactic use of antioxidant vitamins for primary and secondary prevention of all-cause mortality and cardiovascular (CDV) events, in persons at risk. Studies were selected if they were randomised controlled trial (RCTs) that compared antioxidant...
- Vitamin E-Related Inhibition of Monocyte 5-Lipoxygenase and Cardiovascular Outcome in Maintenance Hemodialysis Patients. Manca-di-Villahermosa, Simone; Giacominelli-Stuffler, Roberto; Angelucci, Clotilde B.; Taccone-Gallucci, Massimo; Maccarrone, Mauro // Recent Patents on Inflammation & Allergy Drug Discovery;Sep2011, Vol. 5 Issue 3, p229
A daily supplement of vitamin E is recommended for the secondary prevention of cardiovascular events in endstage renal disease patients on maintenance hemodialysis. Vitamin E has been entrusted with therapeutic properties against cardiovascular disease for more than 60 years. Several...
- It's still the one. Reichert, Ronald G. // Alive: Canada's Natural Health & Wellness Magazine;May2005, Issue 271, p76
Focuses on the health benefits of vitamin E in reducing cardiovascular disease. Role of vitamin E in atherosclerosis; Link of C-reactive protein to increased risk of heart disease; Symptoms of advanced heart problems.
- Role of Oxidants and Antioxidants in Atherosclerosis: Results of In Vitro and In Vivo Investigations. Siekmeier, Rüdiger; Steffen, Christian; März, Winfried // Journal of Cardiovascular Pharmacology & Therapeutics;Dec2007, Vol. 12 Issue 4, p265
The article describes the results of in vitro and in vivo studies on the role of oxidants and antioxidants in the pathomechanism of atherosclerosis. Epidemiological studies and the protective effect of vitamin E against atherosclerosis are discussed. Animal studies that were presented confirmed...
- Nutritional characteristics and consumer acceptability of sausages with different combinations of goat and beef meats. Malekian, Fatemeh; Khachaturyan, Margarita; Gebrelul, Sebhatu; Henson, James F. // Functional Foods in Health & Disease;2016, Vol. 6 Issue 1, p42
Background: Obesity and cardiovascular heart diseases are becoming more prevalent in the United States. This is partly due to the increasing consumption of red meats, such as pork and beef. However, goat meat has the potential to replace these traditionally consumed meats. Rice bran is a rich...
- Taking another look at vitamin E. Braun, Lesley // Australian Journal of Pharmacy;May2009, Vol. 90 Issue 1068, p50
The article reports on the significance of Vitamin E in human health. It indicates that the vitamin inhibits platelet aggregation and adhesion, has an anti-inflammatory effect on monocytes, improves endothelial function, and decrease lipid peroxidation. It highlights several studies that...
- Does vitamin E cause heart failure? Gaby, Alan R. // Townsend Letter for Doctors & Patients;Aug/Sep2004, Issue 253/254, p34
Focuses on the influence of vitamin E to the onset of heart failure. Consideration of Vitamin E as a cardiovascular risk factor; Outcome of the studies of vitamin E supplementation for heart disease prevention; Controversy regarding the potential of Vitamin E as treatment for heart disease.